(AGENPARL) – SILVER SPRING mer 12 aprile 2023 The strength data element in a listing SPL is designed to accept submissions mostly in concentrations of w/w or w/v format, when the strength of an active ingredient is expressed as a percentage.
Fonte/Source: http://www.fda.gov/drugs/electronic-drug-registration-and-listing-system-edrls/strength-conversion-drug-listing